These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 37693814)
1. Genetic risks of Alzheimer's by Huang W; Zeng J; Jia L; Zhu D; O'Brien J; Ritchie C; Shu N; Su L Brain Commun; 2023; 5(5):fcad234. PubMed ID: 37693814 [TBL] [Abstract][Full Text] [Related]
2. The effect of MAPT H1 and APOE ε4 on transition from mild cognitive impairment to dementia. Samaranch L; Cervantes S; Barabash A; Alonso A; Cabranes JA; Lamet I; Ancín I; Lorenzo E; Martínez-Lage P; Marcos A; Clarimón J; Alcolea D; Lleó A; Blesa R; Gómez-Isla T; Pastor P J Alzheimers Dis; 2010; 22(4):1065-71. PubMed ID: 20930301 [TBL] [Abstract][Full Text] [Related]
3. Anxiety correlates with cortical surface area in subjective cognitive decline: APOE ε4 carriers versus APOE ε4 non-carriers. Sun Y; Wang X; Wang Y; Dong H; Lu J; Scheininger T; Ewers M; Jessen F; Zuo XN; Han Y Alzheimers Res Ther; 2019 Jun; 11(1):50. PubMed ID: 31159873 [TBL] [Abstract][Full Text] [Related]
4. Interaction with the MAPT H1H1 Genotype Increases Dementia Risk in APOE ε4 Carriers in a Population of Southern India. Jairani PS; Aswathy PM; Gopala S; Verghese J; Mathuranath PS Dement Geriatr Cogn Disord; 2016; 42(5-6):255-264. PubMed ID: 27705964 [TBL] [Abstract][Full Text] [Related]
5. Selective brain gray matter atrophy associated with APOE ε4 and MAPT H1 in subjects with mild cognitive impairment. Goñi J; Cervantes S; Arrondo G; Lamet I; Pastor P; Pastor MA J Alzheimers Dis; 2013; 33(4):1009-19. PubMed ID: 23064258 [TBL] [Abstract][Full Text] [Related]
6. Sex modifies APOE ε4 dose effect on brain tau deposition in cognitively impaired individuals. Yan S; Zheng C; Paranjpe MD; Li Y; Li W; Wang X; Benzinger TLS; Lu J; Zhou Y Brain; 2021 Nov; 144(10):3201-3211. PubMed ID: 33876815 [TBL] [Abstract][Full Text] [Related]
7. The Sánchez-Juan P; Moreno S; de Rojas I; Hernández I; Valero S; Alegret M; Montrreal L; García González P; Lage C; López-García S; Rodrííguez-Rodríguez E; Orellana A; Tárraga L; Boada M; Ruiz A Front Aging Neurosci; 2019; 11():327. PubMed ID: 31866851 [TBL] [Abstract][Full Text] [Related]
8. Astrocytic function is associated with both amyloid-β and tau pathology in non-demented Spotorno N; Najac C; Stomrud E; Mattsson-Carlgren N; Palmqvist S; van Westen D; Ronen I; Hansson O Brain Commun; 2022; 4(3):fcac135. PubMed ID: 35702728 [TBL] [Abstract][Full Text] [Related]
9. An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology. Wider C; Ross OA; Nishioka K; Heckman MG; Vilariño-Güell C; Jasinska-Myga B; Erketin-Taner N; Rademakers R; Graff-Radford NR; Mash DC; Papapetropoulos S; Duara R; Uchikado H; Wszolek ZK; Farrer MJ; Dickson DW J Neurol Neurosurg Psychiatry; 2012 Apr; 83(4):424-9. PubMed ID: 22291217 [TBL] [Abstract][Full Text] [Related]
10. APOE modifies the interaction of entorhinal cerebral blood flow and cortical thickness on memory function in cognitively normal older adults. Hays CC; Zlatar ZZ; Meloy MJ; Bondi MW; Gilbert PE; Liu TT; Helm JL; Wierenga CE Neuroimage; 2019 Nov; 202():116162. PubMed ID: 31493534 [TBL] [Abstract][Full Text] [Related]
11. APOE associated hemispheric asymmetry of entorhinal cortical thickness in aging and Alzheimer's disease. Donix M; Burggren AC; Scharf M; Marschner K; Suthana NA; Siddarth P; Krupa AK; Jones M; Martin-Harris L; Ercoli LM; Miller KJ; Werner A; von Kummer R; Sauer C; Small GW; Holthoff VA; Bookheimer SY Psychiatry Res; 2013 Dec; 214(3):212-20. PubMed ID: 24080518 [TBL] [Abstract][Full Text] [Related]
12. The effect of APOE and other common genetic variants on the onset of Alzheimer's disease and dementia: a community-based cohort study. van der Lee SJ; Wolters FJ; Ikram MK; Hofman A; Ikram MA; Amin N; van Duijn CM Lancet Neurol; 2018 May; 17(5):434-444. PubMed ID: 29555425 [TBL] [Abstract][Full Text] [Related]
13. Butyrylcholinesterase K and apolipoprotein ε4 affect cortical thickness and neuropsychiatric symptoms in Alzheimer's disease. Yoo HB; Lee HW; Shin S; Park SW; Choi JS; Jung HY; Cha J; Lee JM; Lee JY Curr Alzheimer Res; 2014 Feb; 11(2):137-44. PubMed ID: 24479631 [TBL] [Abstract][Full Text] [Related]
14. Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease. Strom A; Iaccarino L; Edwards L; Lesman-Segev OH; Soleimani-Meigooni DN; Pham J; Baker SL; Landau SM; Jagust WJ; Miller BL; Rosen HJ; Gorno-Tempini ML; Rabinovici GD; La Joie R; Brain; 2022 Apr; 145(2):713-728. PubMed ID: 34373896 [TBL] [Abstract][Full Text] [Related]
16. Effects of APOE-ε4 allele load on brain morphology in a cohort of middle-aged healthy individuals with enriched genetic risk for Alzheimer's disease. Cacciaglia R; Molinuevo JL; Falcón C; Brugulat-Serrat A; Sánchez-Benavides G; Gramunt N; Esteller M; Morán S; Minguillón C; Fauria K; Gispert JD; Alzheimers Dement; 2018 Jul; 14(7):902-912. PubMed ID: 29605385 [TBL] [Abstract][Full Text] [Related]
17. An exploratory study on STX6, MOBP, MAPT, and EIF2AK3 and late-onset Alzheimer's disease. Liu QY; Yu JT; Miao D; Ma XY; Wang HF; Wang W; Tan L Neurobiol Aging; 2013 May; 34(5):1519.e13-7. PubMed ID: 23116876 [TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease. Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O; JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367 [TBL] [Abstract][Full Text] [Related]
20. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum. Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT; Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]